Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

计划入组 30 人 · 首次发布于 2025 年 3 月 19 日

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

首次发布于 2006 年 6 月 12 日

Bioequivalence Study of Vildagliptin From Gliptus 50 mg Tablet (EVA Pharma, Egypt) and Galvus 50 mg Tablet (NOVARTIS PHARMA, GERMANY)

计划入组 24 人 · 首次发布于 2016 年 6 月 29 日

Weed/MPL-containing Pollinex allergy desensitization vaccine(Paladin Pharma SpA)

WEEV prophylactic vaccine (Paladin)

Anti-TAG-72 monoclonal antibody(Paladin Labs, Inc.)

Paladin Labs, Inc.

Canada

Bioprojet Pharma

Belgium

ACASTI PHARMA INC

United States

Endo and Paladin Pharma Partner to Launch Wynzora Cream in Canada for Plaque Psoriasis

Knight Therapeutics to Acquire Paladin in $120 Million Strategic Pharmaceutical Deal

SK Life Science to Present Comprehensive Cenobamate Data and Patient-Provider Communication Study at AAN 2026